SCHEMBL22700684

SCHEMBL22700684

CC(=O)Oc1cc2c(c(C(C)C)c1O)C(=O)C(C)=C(C1=C(C)C(=O)c3c(c(C=O)c(O)c(O)c3C(C)C)C1=O)C2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.39
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 3/20 0.39
USP2 O75604 3/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 3/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 3/20 0.39
MAPK1 P28482 3/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
POLB P06746 2/20 0.39
GAA P10253 2/20 0.39
THRB P10828 2/20 0.39
ALOX12 P18054 2/20 0.39
BLM P54132 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PKM P14618 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22700711 0.88 MCL1 (0.38) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700754 0.88 ALB (0.34) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700685 0.87 MAPT (0.35) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700391 0.86 ALB (0.33) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700393 0.86 ALB (0.37) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700538 0.84 ALB (0.32) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700702 0.84 KDM4E (0.32) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22686504 0.84 ALB (0.42) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700789 0.83 CASP7 (0.37) MCL1KDM4EMEN1USP2ALDH1A1
SCHEMBL22700776 0.82 ALB (0.33) MCL1KDM4EMEN1USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF Nearmedic International Limited (CY) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF DNM2, DNM1, MAVS MCL1 3671/4885KDM4E 2116/4885MEN1 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.